Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
BI 11634 ER vs IR in healthy males
NCT02214953Phase 1Completed
- Sponsor
- Boehringer Ingelheim
- Start
- Oct 2007
- Primary completion
- Dec 2007
01
Overview
Phase 1, randomised, open-label trial of BI 11634 in thromboembolism and Atrial fibrillation (AFib), sponsored by Boehringer Ingelheim. Started Oct 2007; status: completed.
02
Drugs
BI 11634
03
Conditions
thromboembolismAtrial fibrillation (AFib)
Beyond the preview
Go deeper on NCT02214953.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02214953.